Oliver Goldhardt

3.7k total citations
24 papers, 317 citations indexed

About

Oliver Goldhardt is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Oliver Goldhardt has authored 24 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 15 papers in Psychiatry and Mental health and 6 papers in Neurology. Recurrent topics in Oliver Goldhardt's work include Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Oliver Goldhardt is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Oliver Goldhardt collaborates with scholars based in Germany, Switzerland and United Kingdom. Oliver Goldhardt's co-authors include Timo Grimmer, Marion Ortner, Janine Diehl‐Schmid, Hans Förstl, Igor Yakushev, Panagiotis Alexopoulos, Viktor Magdolen, Dennis M. Hedderich, Ilijana Begcevic and Eleftherios P. Diamandis and has published in prestigious journals such as Frontiers in Pharmacology, Journal of Nuclear Medicine and Journal of Alzheimer s Disease.

In The Last Decade

Oliver Goldhardt

22 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oliver Goldhardt Germany	10	150	119	60	57	43	24	317
Naira Goukasian United States	12	209 1.4×	160 1.3×	79 1.3×	49 0.9×	73 1.7×	23	365
Sarah Westwood United Kingdom	7	183 1.2×	144 1.2×	103 1.7×	44 0.8×	41 1.0×	8	324
Jasmine Rivolta Italy	7	166 1.1×	163 1.4×	56 0.9×	61 1.1×	37 0.9×	14	351
Hairong Liao China	5	127 0.8×	77 0.6×	86 1.4×	70 1.2×	21 0.5×	9	337
Anette Hall Finland	14	199 1.3×	230 1.9×	105 1.8×	65 1.1×	50 1.2×	29	455
Elizabeth Joe United States	8	192 1.3×	108 0.9×	114 1.9×	130 2.3×	45 1.0×	19	497
Pierre‐François Meyer Canada	9	166 1.1×	99 0.8×	40 0.7×	86 1.5×	34 0.8×	19	282
Natasha Krishnadas Australia	13	224 1.5×	164 1.4×	61 1.0×	82 1.4×	61 1.4×	35	415
Randolph D. Andrews United States	10	230 1.5×	125 1.1×	99 1.6×	40 0.7×	34 0.8×	20	479
Anna L. Svenningsson Sweden	4	275 1.8×	257 2.2×	76 1.3×	75 1.3×	47 1.1×	5	390

Countries citing papers authored by Oliver Goldhardt

Since Specialization

Citations

This map shows the geographic impact of Oliver Goldhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Goldhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Goldhardt more than expected).

Fields of papers citing papers by Oliver Goldhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Goldhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Goldhardt. The network helps show where Oliver Goldhardt may publish in the future.

Co-authorship network of co-authors of Oliver Goldhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Goldhardt. A scholar is included among the top collaborators of Oliver Goldhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Goldhardt. Oliver Goldhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manuilova, Ekaterina, et al.. (2025). Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer s & Dementia. 21(10). e70797–e70797.

Goldhardt, Oliver, Hans Förstl, Dennis M. Hedderich, et al.. (2023). Head‐to‐head comparison of CSF AD biomarker assays: fully‐automated high‐throughput platforms (ECLIA and CLEIA) vs ELISA. Alzheimer s & Dementia. 19(S24).

Ortner, Marion, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2023). Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease. Journal of Alzheimer s Disease. 93(4). 1537–1549. 2 indexed citations

Ortner, Marion, Udo Eichenlaub, Oliver Goldhardt, et al.. (2022). The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort. Alzheimer s Research & Therapy. 14(1). 36 indexed citations

Ortner, Marion, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2022). Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration. The Journal of Prevention of Alzheimer s Disease. 9(3). 491–498. 6 indexed citations

Berthele, Achim, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2022). Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers. Alzheimer s Research & Therapy. 14(1). 61–61. 21 indexed citations

Berthele, Achim, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2022). Cerebrospinal Fluid Lactate Levels along the Alzheimer’s Disease Continuum and Associations with Blood‐Brain Barrier Integrity, Age, Cognition and Biomarkers. Alzheimer s & Dementia. 18(S5). 1 indexed citations

Ortner, Marion, Heike Schneider, Katharina Büerger, et al.. (2020). Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels. Frontiers in Pharmacology. 11. 691–691. 5 indexed citations

Goldhardt, Oliver, Robert H. Freiberger, Marion Ortner, et al.. (2020). Intrathecal antibodies against herpes simplex virus are associated with tau pathology in humans with Alzheimer’s disease. Alzheimer s & Dementia. 16(S4). 1 indexed citations

10.

Hedderich, Dennis M., Oliver Goldhardt, Marion Ortner, et al.. (2020). Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease. Frontiers in Psychiatry. 11. 7 indexed citations

11.

Grimmer, Timo, Juliane Winkelmann, Matias Wagner, et al.. (2020). Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 21(5-6). 389–395. 2 indexed citations

12.

Grimmer, Timo, Alexander Hapfelmeier, Tamara Eisele, et al.. (2020). The overnight reduction of amyloid β 1‐42 plasma levels is diminished by the extent of sleep fragmentation, sAPP‐β, and APOE ε4 in psychiatrists on call. Alzheimer s & Dementia. 16(5). 759–769. 9 indexed citations

13.

Ortner, Marion, Oliver Goldhardt, Janine Diehl‐Schmid, et al.. (2019). Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease. BMC Neurology. 19(1). 264–264. 16 indexed citations

14.

Grimmer, Timo, Oliver Goldhardt, Igor Yakushev, et al.. (2019). Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer’s Disease. Neurodegenerative Diseases. 19(1). 43–50. 9 indexed citations

15.

Goldhardt, Oliver, Igor Yakushev, Ilijana Begcevic, et al.. (2019). Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET. Translational Neurodegeneration. 8(1). 25–25. 20 indexed citations

16.

Begcevic, Ilijana, Davor Brinc, Marshall Brown, et al.. (2018). Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach. Journal of Proteomics. 182. 12–20. 56 indexed citations

17.

Hedderich, Dennis M., Judith Spiro, Oliver Goldhardt, et al.. (2018). Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer’s Disease by User-Independent, Web-Based Whole-Brain Volumetry. Journal of Alzheimer s Disease. 65(4). 1459–1467. 8 indexed citations

18.

Grimmer, Timo, Panagiotis Alexopoulos, Alexander Drzezga, et al.. (2015). Visual Versus Fully Automated Analyses of ¹⁸F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Journal of Nuclear Medicine. 57(2). 204–207. 44 indexed citations

19.

Grimmer, Timo, Victoria Kehl, Panagiotis Alexopoulos, et al.. (2015). Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985–2009. International Psychogeriatrics. 27(12). 1939–1944. 20 indexed citations

20.

Grimmer, Timo, Oliver Goldhardt, Liang‐Hao Guo, et al.. (2014). LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo. NeuroImage Clinical. 4. 411–416. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact